Management & Regulatory

Chloe Botaine sat down with Ivan Kairatov, a Biopharma expert with deep R&D and tech experience, to discuss the European Commission’s approval of a long-acting monoclonal antibody for RSV prevention in newborns and infants. With a single intramuscular dose designed to protect for up to five months,

Swift regulatory action upended a fragile corner of San Antonio’s behavioral health system when federal officials moved to terminate Medicare and Medicaid participation for a major psychiatric hospital that treats children, adolescents, adults, veterans, and people with substance use disorders,

Matthias Aizenberg sits down with Ivan Kairatov, a biopharma expert whose work straddles gene editing and viral delivery, to unpack a new way of building better gene-editing vehicles by rethinking the cells that make them. Rather than only re-engineering virus-like particles, his team interrogated

Growing strain on MRI services collided with sharpening concerns over safety, supply, and sustainability, forcing radiology to rethink the chemistry behind contrast enhancement at scale, where about a third of scans depend on it for clarity that shapes life-changing decisions. That collision set

The strategic decision by Norfolk County councillors to authorize the sale of the Port Rowan Medical Centre represents a pivotal moment in the municipality's ongoing effort to divest itself from non-essential real estate holdings and focus on core service delivery. Located at 1035 Bay Street, this

The landscape of global pharmaceuticals is currently witnessing a profound architectural shift as legacy regulatory frameworks, once characterized by redundant clinical hurdles, give way to a streamlined, evidence-based approach designed to democratize access to biological therapies. For several